Ayrton Bangolo | Oncology | Best Researcher Award

Posted on by ScienceFather

Dr. Ayrton Bangolo | Oncology | Best Researcher Award

Dr at Hackensack University Medical Center, United States

Dr. Ayrton I. Bangolo, MBBS, MD, is a board-certified internal medicine physician and current Hematology and Oncology fellow at Hackensack University Medical Center, New Jersey. With extensive medical training spanning across multiple countries, he graduated from Tianjin Medical University in China with an MBBS and gained ECFMG certification after excelling in USMLE exams. Dr. Bangolo has held significant positions in various esteemed medical institutions, including a residency at Palisades Medical Center, NJ. He has showcased his expertise through clinical practice, externships, and observerships in internal medicine, endocrinology, nephrology, and interventional radiology. His dedication to research and community health has been recognized with accolades such as awards at HMH research day. Dr. Bangoloā€™s background is enriched with a global perspective, which contributes to his comprehensive approach to patient care and medical innovation.

Profile

Scholar

Education šŸŽ“

Ph.D. Fellowship in Hematology and Oncology (2024-Present): Hackensack University Medical Center, NJ, enrolled in an ACGME-accredited program. Residency in Internal Medicine (2021-2024): Palisades Medical Center, North Bergen, NJ, successfully completed a full-term ACGME-accredited residency. Transitional Year Residency (2020-2021): Palisades Medical Center, NJ, completed with exemplary performance. MBBS Degree (June 2016): Tianjin Medical University, China, graduated with credentials equivalent to MD. USMLE Certification: Passed USMLE Steps 1, 2 CK, and 3 on the first attempt, affirming ECFMG certification and eligibility for medical licensure in the U.S. Externships and Observerships: Clinical experience at Endocrine Associates, Nortonā€™s Suburban Hospital, and Ngaliema Clinic among others, contributing to multidisciplinary expertise in internal medicine and specialty areas.

Ā Experience šŸ’¼

Hematology and Oncology Fellow (2024-Present): Hackensack University Medical Center, NJ, contributing to advanced clinical research and patient care in an ACGME-accredited fellowship. Internal Medicine Residency (2021-2024): Palisades Medical Center, North Bergen, NJ, completed core rotations with a focus on comprehensive patient care. Transitional Year Residency (2020-2021): Provided care across multiple medical disciplines at Palisades Medical Center, NJ. Externship in Endocrinology (2019-2020): Engaged in specialized practice under Dr. Hisham Alrefai at Endocrine Associates, KY. Observership in Nephrology (2019): Gained nephrology insights with Dr. Mohammed El Kheir at Nortonā€™s Suburban Hospital, KY. Interventional Radiology Observership (2019): Participated under Dr. Mahmoud Samman, contributing to a deeper understanding of interventional procedures. Clinical Clerkship (2015-2016): Acquired foundational medical practice skills at Ngaliema Clinic, DR Congo.

Awards and Honors šŸ†

2nd Place Research Poster: Honored for the study ā€œRacial/Ethnic and Socioeconomic Differences in Colon Cancer Surgeryā€ during the HMH North Region Fellow/Residents Research Day. UN Sustainable Development Goals Contribution: Published impactful research with Elsevier (2019-2021), emphasizing global health initiatives. Recognition for Excellence: Commended for clinical contributions during externships and observerships in Kentucky. Top Medical Graduate: Recognized as a distinguished graduate from Tianjin Medical University. USMLE Success: Passed all USMLE examinations on the first attempt, underscoring strong academic and practical medical knowledge.

Research Focus šŸ”

Hematology & Oncology: Ongoing research in treatment protocols and health disparities, focusing on patient outcomes and innovative care practices. Racial and Socioeconomic Health Disparities: Investigated disparities in surgical treatments for colon cancer, contributing to policy discussions and medical strategies. Global Health Contributions: Published research aligning with United Nationsā€™ goals, influencing international health practices. Medical Imaging & Diagnostics: Explored advancements in imaging for early disease detection and effective management. Endocrinology & Nephrology: Applied deep learning to medical data for better diagnostic outcomes and patient treatment plans. Patient Care & Clinical Innovation: Emphasizes integrative methods in patient treatment, fostering evidence-based and empathetic healthcare practices.

Conclusion šŸ“

Dr. Ayrton I. Bangoloā€™s proven track record in clinical practice, research contributions, and scholarly publications position him as a strong contender for the Best Researcher Award. His focus on impactful research and addressing health disparities is commendable. By expanding his research collaborations and further emphasizing his mentorship roles, Dr. Bangoloā€™s candidacy would be even more compelling.

Publications šŸ“š

  • Title: Ultrasound performance using the EU-TIRADS score in the diagnosis of thyroid cancer in Congolese hospitals
    Authors: J Bukasa-Kakamba, P Bayauli, N Sabbah, J Bidingija, A Atoot, B Mbunga, …
    Year: 2022
    Journal: Scientific Reports 12 (1), 18442
    Citations: 9

 

  • Title: Racial/ethnic and socioeconomic differences in breast cancer surgery performed and delayed treatment: mediating impact on mortality
    Authors: P Fwelo, KOS Nwosu, TE Adekunle, O Afolayan, O Ahaiwe, AA Ojaruega, …
    Year: 2023
    Journal: Breast Cancer Research and Treatment 199 (3), 511-531
    Citations: 7

 

  • Title: Epidemiologic risk factors for patients admitted with chronic pancreatitis and pancreatic ductal adenocarcinoma in the United States
    Authors: D Lew, F Kamal, K Phan, K Randhawa, S Cornwell, AI Bangolo, …
    Year: 2022
    Journal: World Journal of Clinical Oncology 13 (11), 907
    Citations: 7

 

  • Title: Impact of gut microbiome in the development and treatment of pancreatic cancer: Newer insights
    Authors: AI Bangolo, C Trivedi, I Jani, S Pender, H Khalid, B Alqinai, A Intisar, …
    Year: 2023
    Journal: World Journal of Gastroenterology 29 (25), 3984
    Citations: 6

 

  • Title: Primary cardiac sarcoma: clinical characteristics and prognostic factors over the past 2 decades
    Authors: A Bangolo, P Fwelo, KM Iyer, S Klinger, L Tavares, S Dey, AA Chacko, …
    Year: 2023
    Journal: Diseases 11 (2), 74
    Citations: 6

 

  • Title: The overall quality of evidence of recommendations surrounding nutrition and diet in inflammatory bowel disease
    Authors: S Weissman, BM Fung, A Bangolo, A Rashid, BF Khan, AKG Tirumala, …
    Year: 2023
    Journal: International Journal of Colorectal Disease 38 (1), 98
    Citations: 6

 

  • Title: The Spectrum of Thyroid Nodules at Kinshasa University Hospital, Democratic Republic of Congo: A Cross-Sectional Study
    Authors: JK Bukasa, P Bayauli-Mwasa, BK Mbunga, A Bangolo, W Kavula, …
    Year: 2022
    Journal: International Journal of Environmental Research and Public Health 19 (23), 16203
    Citations: 6

 

  • Title: Outcomes of patients with gastrointestinal stromal tumors in the past decade
    Authors: A Bangolo, P Fwelo, T Al-Qatish, J Bukasa-Kakamba, T Lee, AG Cayago, …
    Year: 2023
    Journal: Medical Sciences 11 (3), 54
    Citations: 5

 

Jianzhong Wang | Prevention and control of infectious diseases | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Jianzhong Wang | Prevention and control of infectious diseases | Best Researcher AwardĀ 

Assoc Prof Dr Jianzhong Wang Jilin Agricultural University China

Jianzhong Wang, an associate professor at Jilin Agricultural University, specializes in designing novel vaccines using genetic engineering. His research focuses on canarypox virus-based vaccine candidates and bacterium-like particles to enhance immune responses in veterinary medicine. With numerous publications and ongoing projects, he aims to address critical health issues in animal diseases and improve vaccination strategies.

profile:

Scopus

šŸŽ“ Academic and Professional Background :

I specialize in the design of novel vaccines using genetic engineering techniques and exploring their immune mechanisms. My educational journey includes a B.Sc. in Animal Science, an M.Sc. in Preventive Veterinary Medicine, and a Ph.D. in the same field. I’ve held various academic positions, culminating in my current role as an associate professor.

šŸ”¬ Research and Innovations:

Completed/Ongoing Research Projects: Developing canarypox virus-based vaccine candidates using CRISPR/Cas9.Citation Index: [Link]Consultancy/Industry Projects: [Details]Books Published (ISBN): [Titles]Patents Published/Under Process: [Details]Journals Published: A single dose of an ALVAC vector-based RABV virus-like particle candidate vaccine induces a potent immune response in mice, cats, and dogs. Emerg Microbes Infect. 2024 Sep 19:2406280.Editorial Appointments: [Details]Collaborations: [Details]Professional Memberships: [Details]Areas of Research: Veterinary Medicine

šŸŒŸ Contributions :

My contributions involve designing studies that lead to significant advancements in vaccine development. I’ve pioneered the use of bacterium-like particles in vaccine technology, which enhances immune responses. My work has been instrumental in addressing critical health issues in veterinary medicine.

Publication:šŸ“

  • Title: Oral vaccination with a recombinant Lactobacillus plantarum expressing the Eimeria tenella rhoptry neck 2 protein elicits protective immunity in broiler chickens infected with Eimeria tenella
    Authors: Zhang, T., Qu, H., Zheng, W., Zhang, J., Wang, N.
    Year: 2024
    Journal: Parasites and Vectors
    Volume: 17
    Issue: 1
    Article Number: 277

 

  • Title: Gut microbiota-derived LCA mediates the protective effect of PEDV infection in piglets
    Authors: Xing, J.-H., Niu, T.-M., Zou, B.-S., Yang, W.-T., Wang, C.-F.
    Year: 2024
    Journal: Microbiome
    Volume: 12
    Issue: 1
    Article Number: 20

 

  • Title: CRISPR/Cas13a-based genome editing for establishing the detection method of H9N2 subtype avian influenza virus
    Authors: Chen, S.-S., Yang, Y.-L., Wang, H.-Y., Yang, W.-T., Wang, C.-F.
    Year: 2024
    Journal: Poultry Science
    Volume: 103
    Issue: 10
    Article Number: 104068

 

  • Title: ASB3 expression aggravates inflammatory bowel disease by targeting TRAF6 protein stability and affecting the intestinal microbiota
    Authors: Cheng, M., Xu, B., Sun, Y., Wang, C., Cao, X.
    Year: 2024
    Journal: mBio
    Volume: 15
    Issue: 9
    Article Number: e0204324

 

  • Title: AhR ligands from LGG metabolites promote piglet intestinal ILC3 activation and IL-22 secretion to inhibit PEDV infection
    Authors: Wang, J., Zhao, Y., Cui, T., Wang, C., Cao, X.
    Year: 2024
    Journal: Journal of Virology
    Volume: 98
    Issue: 8

 

  • Title: Antibacterial Plasma Coating with Aggregation-Induced Emission Photosensitizers to Prevent Surgical Site Infections
    Authors: Sahu, R., Ninan, N., Nguyen, N.H., Truong, V.K., Tang, Y.
    Year: 2024
    Journal: Advanced Materials Interfaces
    Volume: 11
    Issue: 15
    Article Number: 2400053

Conclusion

In conclusion, Jianzhong Wang’s innovative research in vaccine development leverages advanced genetic engineering techniques to enhance immune responses in veterinary medicine. His contributions not only advance scientific understanding but also address pressing health challenges in animal populations. With a strong publication record and ongoing projects, his work exemplifies a commitment to improving vaccine efficacy and animal health.

Teng Zhang | Gynecologic Oncology | Young Scientist Award

Posted on by ScienceFather

Ms. ā€ŒTeng Zhang |Gynecologic Oncology |Young Scientist AwardĀ 

Ms at Qilu Hospital of Shandong University, China

Ms. Teng Zhang is an accomplished Attending Doctor in the Department of Obstetrics and Gynecology at Qilu Hospital of Shandong University. With a Ph.D. and Master’s degree from Cheeloo College of Medicine, Shandong University, and a Bachelor’s degree from Jining Medical College, Ms. Zhang has extensive experience in clinical practice and research. Notable achievements include publications on cervical cancer in high-impact journals and awards in English teaching competitions. Dr. Zhang’s research focuses on fertility-sparing treatments, m6A methylation, and immune cell variations in cervical cancer, underscoring a strong commitment to advancing women’s health.

Profile

 

šŸŽ“ Education Background

Sept. 2015 – Sep. 2018: Ph.D., Cheeloo College of Medicine, Shandong University. Sept. 2013 – Sep. 2015: Master, Cheeloo College of Medicine, Shandong University. Sept. 2008 – Jun. 2013: Bachelor of Medicine, Jining Medical College. Sept. 2005 – Jun. 2008: Qingdao No.2 Middle School

šŸ’¼ Research/Work Experience

July 2022 – Present: Attending Doctor, Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University. Nov. 2018 – June 2021: Resident, Department of Gynecology and Obstetrics, Qilu Hospital of Shandong University. June 2016 – June 2017: Visiting Scholar, Griffith University, Australia

šŸ† Scholarships and Awards

2023: Young Teachers English Teaching Competition, Second Prize, Cheeloo College of Medicine, Shandong University, 2021: The First “Guangzhi Cup” English Teaching Competition in Qilu Hospital of Shandong University, Third Prize, July 2013: Excellent Graduate of Shandong Province, Oct. 2009: National Scholarship

Publications Top Notes šŸ“

  • Xuji Jiang, Chuanli Feng, Wanying Sun, Teng Zhang*, Baoxia Cui. “The top 100 most cited articles on fertility-sparing treatments for cervical cancer: A bibliometric analysis.” Heliyon, 10(11), 2024.

 

  • Zhonghao Mao, Bingyu Wang, Teng Zhang, Baoxia Cui*. “The roles of m6A methylation in cervical cancer: functions, molecular mechanisms, and clinical applications.” Cell Death and Disease, 2023, 14(734).

 

  • Teng Zhang, Jun Jiao, Xinlin Jiao, Lu Zhao, Xinli Tian, Qing Zhang, Daoxin Ma, Baoxia Cui*. “Aberrant frequency of TNFR2+ Treg and related cytokines in patients with CIN and cervical cancer.” Oncotarget, 2017, 9(4).

 

  • Bingyu Wang, Zhonghao Mao, Jinwen Ye, Xinlin Jiao, Teng Zhang, Qi Wang, Sai Han, Youzhong Zhang, Chunling Wang, Taotao Dong, Baoxia Cui. “Glycolysis Induced by METTL14 Is Essential for Macrophage Phagocytosis and Phenotype in Cervical Cancer.” The Journal of Immunology, 2024, 15(212).

 

  • Zhang W, Tian X, Mumtahana F, Jiao J, Zhang T, Croce K.D., Cui B*. “The existence of Th22, pure Th17 and Th1 cells in CIN and Cervical Cancer along with their frequency variation in different stages of cervical cancer.” BMC Cancer, 2015, 15,717.

 

  • Jun Jiao, Teng Zhang, Xinlin Jiao, Tingting Huang, Lu Zhao, Daoxin Ma, Baoxia Cui*. “hsa_circ_0000745 promotes cervical cancer by increasing cell proliferation, migration, and invasion.” J Cell Physiol, 2019, 1-9.

 

  • Xinlin Jiao, Siying Zhang, Jun Jiao, Teng Zhang, Wenjie Qu, Guy Mutangala Muloye, Beihua Kong, Qing Zhang, Baoxia Cui*. “Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance.” Clin Epigenetics, 2019, 11(120).